Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON30648
NL-OMON30648
Completed
Not Applicable

Methylphenidate ADHD and SUD Study - MASS (Dutch: MAVO)

Trimbos-instituut0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsverslavingsproblematiekMinimal Brain DysfuntionAddiction10009841

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
verslavingsproblematiek
Sponsor
Trimbos-instituut
Enrollment
50
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •age: 18\-65
  • •ADHD according to DSM IV TR criteria
  • •Alcohol and/or Cocaine dependence acoording to DSM IV TR criteria. In case of abuse this must be severe in such a way that the patient and his family suffer from severe negative consequenses of this abuse.

Exclusion Criteria

  • •severe psychiatric comorbidity (which need interventions first)
  • •opiod abuse/dependence
  • •severe physical problems
  • •cardial problems

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Effect of methylphenidate formulation on ADHD-patients' adherence to medical treatment. A comparison of Medikinet retard® (ER) once daily and Medikinet® (IR) twice daily in children and adolescents diagnosed with ADHD - Adherence to stimulant treatment in ADHD-patientsEffect of methylphenidate formulation on ADHD-patients adherence to treatmentMedDRA version: 9.1Level: LLTClassification code 10064104Term: ADHD
EUCTR2008-003285-26-DEniversität Mainz, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und -psychotherapie
Completed
Phase 3
Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)Attention Deficit Disorder With Hyperactivity
NCT00018863New York State Psychiatric Institute165
Active, not recruiting
Not Applicable
Therapeutic effect of Metadate in ADHD patients with somatic symptoms
KCT0003866Chung-Ang Univerisity Hospital30
Completed
Not Applicable
A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in JapanAttention Deficit Disorder With Hyperactivity
NCT04113551Janssen Research & Development, LLC17,418
Completed
Not Applicable
Methylphenidate for Treating Children With ADHD and Tourette SyndromeAttention Deficit Disorder With HyperactivityTourette Syndrome
NCT00441649Stony Brook University71